YouTube Facebook LinkedIn Google+ Twitter Xingrss  

More Big Pharma Shakeup: Novartis, GSK Trade Assets


April 22, 2014 | Novartis and GlaxoSmithKline announced this morning that they two big pharma are trading over $20 billion worth of assets in an attempt to strengthen their best businesses. Novartis will acquire GSK's cancer drugs; GSK will take Novartis' vaccines business. Reuters
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.